APA (7th ed.) Citation

P, K., R, F., SV, R., S, S., MA, G., AK, S., . . . Sinha, S. (2010). Evidence for cytogenetic and fluorescence in situ hybridization risk stratification of newly diagnosed multiple myeloma in the era of novel therapie. Mayo Clinic Proceedings, 85(6), 532. https://doi.org/10.4065/mcp.2009.0677

Chicago Style (17th ed.) Citation

P, Kapoor, et al. "Evidence for Cytogenetic and Fluorescence in Situ Hybridization Risk Stratification of Newly Diagnosed Multiple Myeloma in the Era of Novel Therapie." Mayo Clinic Proceedings 85, no. 6 (2010): 532. https://doi.org/10.4065/mcp.2009.0677.

MLA (9th ed.) Citation

P, Kapoor, et al. "Evidence for Cytogenetic and Fluorescence in Situ Hybridization Risk Stratification of Newly Diagnosed Multiple Myeloma in the Era of Novel Therapie." Mayo Clinic Proceedings, vol. 85, no. 6, 2010, p. 532, https://doi.org/10.4065/mcp.2009.0677.